PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab

Background: Tumor microenvironment may have a key role in providing immunological markers that can help predict clinical response to treatment with checkpoint inhibitors. We investigated whether the baseline expression of PD-L1 in advanced melanoma patients treated with ipilimumab may correlate with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Autores principales: Madonna, Gabriele, Ballesteros-Merino, Carmen, Feng, Zipei, Bifulco, Carlo, Capone, Mariaelena, Giannarelli, Diana, Mallardo, Domenico, Simeone, Ester, Grimaldi, Antonio M., Caracò, Corrado, Botti, Gerardo, Fox, Bernard A., Ascierto, Paolo A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6279420/
https://ncbi.nlm.nih.gov/pubmed/30524879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1405206
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares